Patents by Inventor Ian Lewis

Ian Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220238036
    Abstract: Methods and systems for remote multiplayer gameplay are disclosed. An example method can include joining a multiplayer interactive physical game including first and second players competing in an activity; capturing a first game video of a first player in a first play of the multiplayer interactive physical game, using a first camera on a first mobile computing device in a first gaming area; determining a first object flow associated with the first player from the first game video, by performing an algorithm on one or more frames of the first game video to detect one or more key points of the first player; generating a first analytic based on the first object flow; receiving a second analytic associated with the second player in a second gaming area; and generating a feedback to the first player based on the first analytic or the second analytic.
    Type: Application
    Filed: April 15, 2022
    Publication date: July 28, 2022
    Inventors: Keng Fai Lee, Qi Zhang, Wing Hung Chan, Wang Fai Ng, Tin Yin Lam, Alexander Wu, Ian Smith, David Richard Schmierer, Bradford Lewis Farkas, Kin Ming Law
  • Publication number: 20220024981
    Abstract: The disclosure relates to inhibitors of PCSK9 useful in the treatment of lipid metabolism, and other diseases in which PCSK9 plays a role, having the Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein R1, X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12, and X13 are described herein.
    Type: Application
    Filed: November 26, 2019
    Publication date: January 27, 2022
    Inventors: Alec Nathanson FLYER, Andrei Alexandrovich GOLOSOV, Philipp GROSCHE, Ian LEWIS, Eugene Yuejin LIU, Andreas MARZINZIK, Lauren Gilchrist MONOVICH, Johannes OTTL, Tajesh Jayprakash PATEL, Patrick Crawford REID, Mohindra SEEPERSAUD
  • Publication number: 20200281964
    Abstract: Provided herein are compositions, for example: oral rehydration compositions, beverages, food items, methods and uses, which utilise resistant starch to prevent or treat dehydration, including dehydration which is caused by diarrhoea. Beverages, food items and oral rehydration solutions including a resistant starch, which are suitable for aiding in the maintenance and restoration of hydration levels in individuals undertaking physical activities, including sports, are also disclosed.
    Type: Application
    Filed: February 12, 2020
    Publication date: September 10, 2020
    Inventors: Balakrishnan Siddartha Ramakrishna, Graeme Paul Young, Ian Lewis Brown, Henry Joseph Binder
  • Patent number: 10596187
    Abstract: Provided herein are compositions, for example: oral rehydration compositions, beverages, food items, methods and uses, which utilise resistant starch to prevent or treat dehydration, including dehydration which is caused by diarrhoea. Beverages, food items and oral rehydration solutions including a resistant starch, which are suitable for aiding in the maintenance and restoration of hydration levels in individuals undertaking physical activities, including sports, are also disclosed.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: March 24, 2020
    Assignees: Yale University, Flinders University of South Australia, Balakrishnan Siddartha Ramakrishna
    Inventors: Balakrishnan Siddartha Ramakrishna, Graeme Paul Young, Ian Lewis Brown, Henry Joseph Binder
  • Publication number: 20200010870
    Abstract: Devices, methods and systems are for identifying the cell type of an unknown microorganism. The device includes: an apparatus for culturing unknown organism(s), a diagnostic data acquisition tool and a computer program. The method includes: incubation of the sample with a growth medium (with or without toxins), and an analysis of the metabolites detected in the sample. The computer system compares the results collected from the device to reference metabolite profiles.
    Type: Application
    Filed: March 13, 2018
    Publication date: January 9, 2020
    Inventor: Ian LEWIS
  • Patent number: 9949979
    Abstract: The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: April 24, 2018
    Assignee: Novartis AG
    Inventors: Nigel Graham Cooke, Paulo Antonio Fernandes Gomes Dos Santos, Pascal Furet, Christina Hebach, Klemens Hoegenauer, Gregory Hollingworth, Christoph Kalis, Ian Lewis, Alexander Baxter Smith, Nicolas Soldermann, Frederic Stauffer, Ross Strang, Frank Stowasser, Nicola Tuffilli, Anette Von Matt, Romain Wolf, Frederic Zecri
  • Patent number: 9763952
    Abstract: The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: September 19, 2017
    Assignee: NOVARTIS AG
    Inventors: Giorgio Caravatti, Sylvie Chamoin, Pascal Furet, Klemens Hogenauer, Konstanze Hurth, Karen Kammertoens, Ian Lewis, Henrik Moebitz, Alexander Baxter Smith, Nicolas Soldermann, Romain Wolf, Frederic Zecri
  • Patent number: 9539260
    Abstract: The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: January 10, 2017
    Assignee: NOVARTIS AG
    Inventors: Giorgio Caravatti, Sylvie Chamoin, Pascal Furet, Klemens Hogenauer, Konstanze Hurth, Karen Kammertoens, Ian Lewis, Henrik Moebitz, Alexander Baxter Smith, Nicolas Soldermann, Romain Wolf, Frederic Zecri
  • Publication number: 20160286838
    Abstract: Provided herein are compositions, for example: oral rehydration compositions, beverages, food items, methods and uses, which utilise resistant starch to prevent or treat dehydration, including dehydration which is caused by diarrhoea. Beverages, food items and oral rehydration solutions including a resistant starch, which are suitable for aiding in the maintenance and restoration of hydration levels in individuals undertaking physical activities, including sports, are also disclosed.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 6, 2016
    Inventors: Balakrishnan Siddartha RAMAKRISHNA, Graeme Paul YOUNG, Ian Lewis BROWN, Henry Joseph BINDER
  • Patent number: 9344543
    Abstract: A system is providing for augmenting multimedia playback on a mobile device. The system includes the mobile device and an auxiliary loudspeaker device. The mobile device includes a telecoil transmitter and is configured to, in a multimedia mode, provide a multimedia audio signal to the telecoil transmitter for transmission to the auxiliary loudspeaker device. The auxiliary loudspeaker device includes a telecoil to receive the transmitted multimedia audio signal and plays a low frequency portion of multimedia audio content at a loudspeaker of the auxiliary loudspeaker device.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: May 17, 2016
    Assignee: Wistron Corporation
    Inventors: Ian Lewis, Michael Burke
  • Publication number: 20160106753
    Abstract: The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
    Type: Application
    Filed: December 21, 2015
    Publication date: April 21, 2016
    Applicant: Novartis AG
    Inventors: Giorgio CARAVATTI, Sylvie CHAMOIN, Pascal FURET, Klemens HOGENAUER, Konstanze HURTH, Christoph KALIS, Karen KAMMERTOENS, Ian LEWIS, Henrik MOEBITZ, Alexander Baxter SMITH, Nicolas SOLDERMANN, Romain WOLF, Frederic ZECRI
  • Publication number: 20160021229
    Abstract: A system is providing for augmenting multimedia playback on a mobile device. The system includes the mobile device and an auxiliary loudspeaker device. The mobile device includes a telecoil transmitter and is configured to, in a multimedia mode, provide a multimedia audio signal to the telecoil transmitter for transmission to the auxiliary loudspeaker device. The auxiliary loudspeaker device includes a telecoil to receive the transmitted multimedia audio signal and plays a low frequency portion of multimedia audio content at a loudspeaker of the auxiliary loudspeaker device.
    Type: Application
    Filed: July 15, 2014
    Publication date: January 21, 2016
    Inventors: Ian Lewis, Michael Burke
  • Publication number: 20150369688
    Abstract: A device, system and method for determining a seal quality of a sealed environment is provided herein. A seal detection device is utilized to determine a seal quality for an acoustic cavity of a microphone for a mobile device. The seal detection device determines an acoustic impedance at the end of a hollow longitudinal section by propagating a broadband audio signal from a source speaker through the hollow longitudinal section into the acoustic cavity. Located within the hollow longitudinal section is a microphone measurement portion configured to provide an output signal to measurement equipment in order to determine a transfer function between of the microphone measurement portion. Utilizing the transfer function, the seal quality can be determined for the acoustic cavity.
    Type: Application
    Filed: June 19, 2014
    Publication date: December 24, 2015
    Inventor: Ian Lewis
  • Publication number: 20150342951
    Abstract: The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.
    Type: Application
    Filed: December 14, 2012
    Publication date: December 3, 2015
    Applicant: NOVARTIS AG
    Inventors: Nigel Graham COOKE, Paulo Antonio FERNANDES GOMES DOS SANTOS, Pascal FURET, Christina HEBACH, Klemens HOGENAUER, Gregory HOLLINGWORTH, Christoph KALIS, Ian LEWIS, Alexander Baxter SMITH, Nicolas SOLDERMANN, Frederic STAUFFER, Ross STRANG, Frank STOWASSER, Nicola TUFFILLI, Anette VON MATT, Romain WOLF, Frederic ZECRI
  • Publication number: 20150218223
    Abstract: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
    Type: Application
    Filed: April 8, 2015
    Publication date: August 6, 2015
    Applicant: Novartis AG
    Inventors: Rainer Albert, Wilfried Bauer, David Bodmer, Christian Bruns, Ivo Felner, Heribert Hellstern, Ian Lewis, Mark Meisenbach, Gisbert Weckbecker, Bernhard Wietfeld
  • Patent number: 9035021
    Abstract: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: May 19, 2015
    Assignee: Novartis AG
    Inventors: Rainer Albert, Wilfried Bauer, David Bodmer, Christian Bruns, Ivo Felner, Heribert Hellstern, Ian Lewis, Mark Meisenbach, Gisbert Weckbecker, Bernhard Wietfeld
  • Publication number: 20140249139
    Abstract: The invention relates to substituted quinazoline derivative of the formula (I), wherein A, X1, X2, X3, X4 and R5 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 4, 2014
    Applicant: NOVARTIS AG
    Inventors: Pascal Furet, Christina Hebach, Klemens Hogenauer, Gregory Hollingworth, Ian Lewis, Alexander Baxter Smith, Nicolas Solvermann, Frederic Stauffer, Romain Wolf, Frederic Zecri
  • Patent number: 8822637
    Abstract: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O-)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: September 2, 2014
    Assignee: Novartis AG
    Inventors: Rainer Albert, Wilfried Bauer, David Bodmer, Christian Bruns, Ivo Felner, Heribert Hellstern, Ian Lewis, Mark Meisenbach, Gisbert Weckbecker, Bernhard Wietfeld
  • Patent number: 8619086
    Abstract: Three dimensional scenes may be managed between a central processing unit and a graphics processing unit using shared and unified graphics processing unit memory. A shared bus memory may be synchronized between the central processing unit and the graphics processing unit. The shared bus memory may be used for more often updated components and other memory may be used for less often updated components. In some embodiments, if the graphics processor and the central processor use a common processor instruction set architecture, data can be sent from the central processor to the graphics processor without serializing the data.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: December 31, 2013
    Assignee: Intel Corporation
    Inventors: Antony Arciuolo, Ian Lewis, Kevin Myers
  • Publication number: 20110172157
    Abstract: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
    Type: Application
    Filed: March 16, 2011
    Publication date: July 14, 2011
    Applicant: NOVARTIS AG
    Inventors: Rainer Albert, Wilfried Bauer, David Bodmer, Christian Bruns, Ivo Felner, Heribert Hellstern, Ian Lewis, Mark Meisenbach, Gisbert Weckbecker, Bernhard Wietfeld